Drainage devices in children can cause abnormal ocular motility

Article

Ocular motility abnormalities and strabismus are common in children after aqueous drainage device surgery and these problems should be taken into account before proceeding with surgery.

Ocular motility abnormalities and strabismus are common in children after aqueous drainage device surgery and these problems should be taken into account before proceeding with surgery, concludes a report published in the February issue of the Journal of the American Association of Pediatric Ophthalmology.

Erin O'Malley and colleagues from Duke University Medical Center, North Carolina, USA conducted a chart review of consecutive children treated with aqueous drainage devices between 1995 and 2006, looking for ocular motility abnormalities and strabismus as well as sensorimotor testing results before and after device placement.

A total of 38 eyes of 30 children with congenital glaucoma and 41 eyes of 32 children with aphakic glaucoma were included in the study. Following drainage device surgery, 14 and 20 eyes were >20/100 in the congenital and aphakic groups, respectively. Horizontal and vertical strabismus was common and occurred in 57% of congenital glaucoma patients and 47% of aphakic glaucoma patients. Motility limitation, both vertical and horizontal, was also common and occurred in 37% of patients overall.

These potential problems should be carefully considered before implanting a drainage device, caution the authors.

Recent Videos
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Vikas Chopra at AAO 2024: Advancements in MIGS are transforming patient care
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.